Kyrgyzstan Medical Device Registration Certificate: Indefinite Validity, Suspension and Revocation

1. Key takeaways

Medical device registration certificates in Kyrgyzstan are issued with indefinite validity. This is set out in Article 15 of Law No. 216, and it changes the logic of product life-cycle management: there is no five-year renewal calendar and no need to schedule submissions ahead of an expiry date. The same article, however, also lists the situations of suspension and revocation: suspension is possible where a potential serious public health risk arises or where there is substantiated evidence of danger to life and health; revocation is possible where false information has been provided, where an effective court judgment exists, where new systematic data show that the risks outweigh the benefits, or where the grounds for suspension have not been removed. There is no expiry date, but there is a brake that can be applied at any time.

2. Legal basis

1. Law of the Kyrgyz Republic On the Circulation of Medical Devices, No. 216 of December 29, 2023, Article 15: registration certificates are issued with indefinite validity; the article also establishes the situations of suspension and revocation (annulment) of registration certificates.
2. Article 14 of Law No. 216: when device data and information change, the reporting obligation falls on the manufacturer or its authorized representative.
3. Cabinet Resolution No. 513 of August 27, 2024, Annex 1: procedures for changes to registration dossiers and for suspension and revocation of registration certificates.
4. Published forms Annex 3 (revocation application form) and Annex 4 (format of the registration certificate) of the competent authority.
5. Published form Annex 10: the declaration by the applicant of responsibility for the truthfulness of the information and documents submitted.

Note on sources: the verbatim official text of each paragraph of the suspension and revocation situations in Article 15 was not obtained in a quotable form for this cycle. They are therefore presented by way of categorization, and concrete application must follow the currently valid legal text.

3. Expert insights

Insight 1: indefinite validity does not mean set-and-forget; it moves the compliance burden from the calendar to the state of the dossier.

In markets with five-year validity, compliance actions are predictable: start renewal three months before expiry, submit, wait. Kyrgyzstan has no such rhythm. What replaces it is state maintenance: the certificate remains valid on the premise that the information recorded in the registration dossier remains continuously true, accurate and consistent with reality. Any deviation may trigger suspension or revocation. What this demands of companies is a routine dossier maintenance mechanism, not a last-minute sprint.

Insight 2: the first ground for revocation, the provision of false information, points directly at the prerequisites.

Article 15 lists the provision of false information as a ground for revocation, closing the loop with Annex 10, the declaration of responsibility for the truthfulness of information published by the competent authority. As discussed in Article 06 of this series, Kyrgyz registration has two prerequisites: confirmation of circulation in the country of origin, and a positive expert evaluation. If either of these is later proven false, the consequence is not correction but revocation. This is also why Annex 10 is not a formality.

Insight 3: new systematic data showing that risks outweigh benefits is a dynamic ground for revocation.

This ground deserves a separate flag. It means the survival of the certificate is bound to the risk-benefit balance of the product, and that balance changes as evidence accumulates. For companies, this effectively ties post-market surveillance data to the survival of the registration certificate — surveillance is not only a reporting obligation but also the safety valve of the certificate (see Articles 41–44 of this series).

Insight 4: suspension and revocation are two levels, not one.

Suspension is a temporary measure, and the certificate can be restored once the grounds are removed; revocation (annulment) is final. The law regulates the two separately, and the practical implication is that the suspension phase is the window for remediation. Upon receiving a suspension notice, the company should immediately assess whether the grounds can be removed and within what period, and stop the relevant circulation activities in the meantime. Missing the remediation window turns the persistence of the grounds itself into a ground for revocation.

Insight 5: we do not adopt the circulating claim of a five-year validity.

Several consulting pages still state that Kyrgyzstan registration certificates are valid for five years. That claim conflicts with the express wording of Article 15 of Law No. 216 on indefinite issuance and with the public position of the competent authority. This series uniformly uses indefinite validity, and the conflict is listed in the not-adopted list of our website content release plan. Readers should note that planning renewal calendars around a validity period taken from a service provider page leads to unnecessary budget spending and disrupted project scheduling.

4. Practical recommendations

First, build a registration dossier status ledger to replace the renewal calendar. Suggested fields: certificate number and issue date, dossier version, certificate holder, authorized representative, production sites, model list, date of the most recent change, and pending change items. Reconcile the ledger with reality once every quarter.

Second, assign the information change reporting obligation to a specific role. Article 14 places the obligation on the manufacturer or its authorized representative but says nothing about internal division of labor. We recommend designating a responsible position in the quality system documents and defining four categories of triggering events: changes to the device itself, changes to manufacturer information, changes to production sites, and changes of authorized representative (see Articles 33 and 35 of this series).

Third, pre-build an emergency response process for suspension. Prepare a response plan in advance: the internal notification path upon receiving a notice, assessment of the grounds, the remediation plan, the division of labor with the authorized representative, and the mechanics of halting circulation. The value of the plan lies in compressing response time.

Fourth, link post-market data to the registration dossier. Given that new systematic data showing risks outweighing benefits is a ground for revocation, we recommend incorporating the periodic review of post-market surveillance data, complaint data and vigilance reports into the annual review of the registration dossier, so that surveillance and registration do not run on separate tracks.

5. Verification checklist

• □ Confirm that the registration certificate is issued with indefinite validity under Article 15 of Law No. 216, with no periodic renewal obligation;
• □ A registration dossier status ledger has been established and is reconciled quarterly;
• □ A responsible position for information change reporting has been designated in the quality system documents;
• □ An emergency response plan for suspension is in place (notification path, assessment of grounds, remediation plan, execution of the circulation halt);
• □ Post-market surveillance, complaint and vigilance data are included in the annual review of the registration dossier;
• □ All external materials have been checked for validity statements, to avoid the incorrect statement of a five-year validity.

Regulatory information verified as of October 29, 2026.

Our services cover pre-market pathway selection and feasibility assessment, registration dossier preparation and submission, authorized representative arrangements, local testing and clinical trial organization, production site inspection coordination, quality management system conformity support, post-market surveillance and device vigilance system setup, import and distribution compliance, official fee calculation and project budget management.

The GRZAN regulatory team consists of professionals with many years of hands-on experience in Eurasian Economic Union registrations. We maintain a stable local cooperation network in Bishkek, Almaty, Tashkent and Moscow, work in Chinese, Russian and English, and provide executable solutions for the issues foreign manufacturers most often encounter in CIS markets, including authorized representative arrangements, the notarization and legalization chain for powers of attorney, localization of technical documentation, and inspection readiness.

We adhere to one principle: every regulatory conclusion we publish must rest on verifiable official sources. Figures and timelines that cannot be verified are always marked as practical estimates, and experience-based values are never presented as legal requirements.

GRZAN provides registration support in Kyrgyzstan for medical device manufacturers, importers and authorized representatives. For project consultation on Kyrgyzstan or Eurasian Economic Union market access, contact us at info@grzanglobal.com.

GRZAN | Global Medical Device Regulatory Registration and Compliance Services